Recent advances in inflammation & allergy drug discovery.

ISSN 2772-2708Bentham Science PublishersUnited Arab Emirates
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Journal identity
Titles
Recent Advances in Inflammation and Allergy Drug Discovery
Recent Adv. Inflamm. Allergy Drug Discov. (abbreviated)
Recent Advances in Inflammation & Allergy Drug Discovery BENTHAM SCIENCE PUBL LTD
Recent advances in inflammation & allergy drug discovery.
Recent Adv Inflamm Allergy Drug Discov (abbreviated)
Key identifiers
ISSN
2772-2708
2772-2708
eISSN
2772-2716
NLM ID
101776469
Publisher / basic metadata
Publisher
Bentham Science Publishers
Netherlands : Bentham Science Publishers, [2021]-
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2021–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF20251.1Q412843JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.391
Best Quartile
Q3
H-index
40
Subject categories
  • Drug Discovery — Q3
  • Immunology and Allergy — Q3
  • Pharmacology (medical) — Q3
More metrics
Coverage
2021–2025
Country
United Arab Emirates
Region
Middle East
Publisher
Bentham Science Publishers
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
57
Total documents (3 years)
48
Total references
4698
Total citations (3 years)
81
Citable documents (3 years)
40
Citations per document (2 years)
1.76
References per document
82.42
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2772-2716, 2772-2708
SCImago Source ID
21101079251
SCImago Rank (across all SCImago source types)
14438

Publication activity

Publication activity
SCImago
2025
57 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Drug Discovery; Hypersensitivity/drug therapy; Inflammation/drug therapy
Coverage / history
Scopus:2021-2026
MEDLINE:MEDLINE: v15, 2021-In: PubMed: v15, 2021-;
PubMed:MEDLINE: v15, 2021-In: PubMed: v15, 2021-;